This is the authors' abstract. We don't add key points for this paper.
Forty-four patients with chronic renal failure on haemodialysis for four months to eight years were studied. All recieved intravenous iron dextran 100 mg on alternate weeks. Serum ferritin concentrations correlated well with body iron stores estimated by grading the bone marrow stainable iron. Altogether 34 patients showed increased bone marrow iron stores and serum ferritin concentrations greater than controls; four patients showed absence of iron in the marrow, and three of these had subnormal serum ferritin concentrations. Serum ferritin assay represents the best method of repeatedly monitoring the exact amount of iron therapy needed by patients with chronic renal failure, particularly those on regular haemodialysis.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hussein et al. (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: